PHA's Research Program

"PHA's research program funds some of the best science and the brightest people in the nation."
- Dr. John Newman, Vanderbilt University Medical Center

beakers in a labPHA's Research Program has committed more than $17 million to support cutting-edge research focused on pulmonary hypertension. PHA has been able to leverage such substantial funding through partnerships with the National Heart, Lung, and Blood Institute (NHLBI) and the Foundation of the American Thoracic Society (ATS).

PHA's grants to promising researchers cultivate new leaders in the field by supporting their interest in PH research and providing them with opportunities to work with mentors and learn new skills. Researchers supported by PHA are looking for new methods for early detection, new treatments to prevent the onset of PH and ultimately a cure for this terrible illness.

Offering five active, independently reviewed cutting-edge research programs each year, PHA has awarded grants to more than 70 researchers since the inception of the program.

Robyn Barst Pediatric PH Research and Mentoring Program

A unique grant opportunity designed to fund mentoring and research opportunities in pediatric PH. In 2016, PHA will offer 3, one-year Barst Fund awards of $50,000.

Learn more | Previous winners

PHA Proof of Concept Research Grants

This program offers support for new research projects that should result in the development of data enabling the investigator to apply for a larger, hypotheses-driven research project. In 2016, PHA will offer 1, one-year Proof of Concept award of $40,000.

Learn more | Previous winners

PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension

A partnership grant program with the Foundation of the American Thoracic Society supporting faculty-level researchers. In 2016, PHA/ATS will offer 1, two-year Research Fellowship award of $80,000.

Apply todayPrevious winners

PHA/NHLBI Mentored Clinical Scientist Award (K08)/Mentored Patient-Oriented Research Career Development Award (K23)

A partnership with the National Heart, Lung, and Blood Institute (NHLBI) that supports junior investigators. In 2016, PHA will offer 1, five-year K08/K23 supplemental award of up to $312,500.

Apply todayPrevious winners

The Aldrighetti Research Award for Young Investigators

This award, named for PHA's first President & CEO, Rino Aldrighetti, was established and sponsorship support provided by Actelion Pharmaceuticals US, Inc.. The program will support the careers of young investigators who are likely to make a strong and sustained impact in PAH research. Established at PHA's 12th International PH Conference and Scientific Sessions in June 2016, PHA will award 1, two-year, $80,000 Aldrighetti Research Award for Young Investigators annually through 2021.


A partnership with the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health that supports a comprehensive, deep-phenotyping across the current World Health Organization (WHO) classifications of pulmonary hypertension (Groups 1 through 5).

Learn more

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Terms of Use    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2017 Pulmonary Hypertension Association. All Rights Reserved.

BBB Accredited Charity BEST in AmericaCharity Navigator

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.